Page last updated: 2024-12-07

eudistomin e

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

eudistomin E: structure known; isolated from the marine tunicate Eudistoma album [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128900
CHEMBL ID510254
MeSH IDM0205067

Synonyms (9)

Synonym
eudistomin e
nsc722497
nsc-722497
88704-51-2
CHEMBL510254
(1,6,2)oxathiazepino(2',3':1,2)pyrido(3,4-b)indol-10-ol, 1-amino-9-bromo-1,2,7,8,13,13b-hexahydro-, (1s-trans)-
DTXSID401008308
1-amino-9-bromo-1,2,7,8,13,13b-hexahydro-4h-[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol-10-ol
(2s,3s)-3-amino-13-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.02,8.012,17]octadeca-1(11),12(17),13,15-tetraen-14-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID334764Cytotoxicity against human KB cells at 0.005 to 10 ug/ml1992Journal of natural products, Apr, Volume: 55, Issue:4
Brominated beta-carbolines from the marine tunicate Eudistoma album.
AID334768Cytotoxicity against human KB cells1992Journal of natural products, Apr, Volume: 55, Issue:4
Brominated beta-carbolines from the marine tunicate Eudistoma album.
AID1419808Antibacterial activity against Micrococcus luteus assessed as inhibition zone at 20 ug2017Journal of natural products, 11-22, Volume: 80, Issue:11
Natural Products with Heteroatom-Rich Ring Systems.
AID1419809Cytotoxicity against mouse L1210 cells assessed as decrease in cell viability at 5 ug2017Journal of natural products, 11-22, Volume: 80, Issue:11
Natural Products with Heteroatom-Rich Ring Systems.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (40.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]